Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Operating Expenses | 6,475 | 6,001 | 5,933 | 5,180 | 4,101 |
| Operating Income | -6,475 | -6,001 | -5,933 | -5,180 | -4,101 |
| Other Income | 70 | 567 | 85 | 26 | 86 |
| Pre-tax Income | -6,405 | -5,434 | -5,848 | -5,154 | -4,015 |
| Net Income Continuous | -6,405 | -5,434 | -5,848 | -5,154 | -4,015 |
| Net Income | $-6,405 | $-5,314 | $-5,848 | $-5,154 | $-4,015 |
| EPS Basic Total Ops | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 |
| EPS Basic Continuous Ops | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 |
| EPS Diluted Total Ops | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 |
| EPS Diluted Continuous Ops | -0.10 | -0.08 | -0.10 | -0.09 | -0.07 |
| EBITDA(a) | $-6,464 | $-5,989 | $-5,918 | $-5,165 | $-4,083 |